Erythropoietin Improves the Accumulation and Therapeutic Effects of Carboplatin by Enhancing Tumor Vascularization and Perfusion

Recombinant human erythropoietin (rhuEpo) is currently under debate for the treatment of chemotherapy-induced anemia due to clinical trials showing adverse effects in Epo-treated patients and the discovery of the erythropoietin-receptor (EpoR) in tumor and endothelial cells. Here, using Epo-Cy5.5 as...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Theranostics
Principais autores: Doleschel, Dennis, Rix, Anne, Arns, Susanne, Palmowski, Karin, Gremse, Felix, Merkle, Ruth, Salopiata, Florian, Klingmüller, Ursula, Jarsch, Michael, Kiessling, Fabian, Lederle, Wiltrud
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2015
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4440446/
https://ncbi.nlm.nih.gov/pubmed/26000061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.11304
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados